Painkiller study for newborns pulled before it started
NCT ID NCT01667120
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study planned to test whether the painkiller ketorolac is safe and effective for newborns (up to 3 months old) after abdominal surgery. Researchers wanted to compare bleeding and pain control between babies given the drug and those given a placebo. However, the study was withdrawn before enrolling any participants, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN CONTROL IN SURGICAL NEONATES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States